{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20237244,Language='DE')/Transcripts"}},"ID":20237244,"Language":"DE","BusinessShortNumber":"23.7244","BusinessType":14,"BusinessTypeName":"Fragestunde. Frage","BusinessTypeAbbreviation":"Fra.","Title":"Arzneimittelengp\u00e4sse: Abh\u00e4ngigkeit von Wirkstoffen aus Asien","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>Die Produktion von grundlegenden Arzneimittelwirkstoffen ist nach und nach in Niedriglohnl\u00e4nder, insbesondere nach China und Indien, verlagert worden.</p><p>Sollte in Asien jedoch eine Krise ausbrechen (zum Beispiel ein Krieg in Taiwan), k\u00f6nnte aus dem derzeitigen Arzneimittelengpass eine regelrechte Katastrophe werden. Ber\u00fccksichtigt die interdisziplin\u00e4re Arbeitsgruppe des Bundes, die mit der Behebung der Arzneimittelenengp\u00e4sse beauftragt ist, solche geopolitischen Risiken?</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":null,"FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":null,"SubmittedBy":"Feller Olivier","BusinessStatus":229,"BusinessStatusText":"Erledigt","BusinessStatusDate":"\/Date(1678665600000)\/","ResponsibleDepartment":8,"ResponsibleDepartmentName":"Departement f\u00fcr Wirtschaft, Bildung und Forschung","ResponsibleDepartmentAbbreviation":"WBF","IsLeadingDepartment":true,"Tags":"9|15|2841","Category":null,"Modified":"\/Date(1694445065793)\/","SubmissionDate":"\/Date(1678233600000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Nationalrat","SubmissionCouncilAbbreviation":"NR","SubmissionSession":5118,"SubmissionLegislativePeriod":51,"FirstCouncil1":1,"FirstCouncil1Name":"Nationalrat","FirstCouncil1Abbreviation":"NR","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"Sicherheitspolitik|Wirtschaft|Gesundheit"}}